Switch theme
Sign up to access all valuation multiples
Agfa-Gevaert NV develops, produces, and distributes a range of analog and digital imaging systems and information technology solutions, for the printing sector, healthcare sector, and specific industrial applications. The company's operating segment includes CONOPS; Digital Print and Chemicals; Radiology Solutions and Healthcare IT. It generates maximum revenue from the Digital Print and Chemicals segment. The company operates in Europe, NAFTA, Latin America and Asia/Oceania/Africa.
1964
5.0K+
LTM Revenue $1.3B
LTM EBITDA $39.8M
$301M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Agfa-Gevaert has a last 12-month revenue (LTM) of $1.3B and a last 12-month EBITDA of $39.8M.
In the most recent fiscal year, Agfa-Gevaert achieved revenue of $1.3B and an EBITDA of -$20.2M.
Agfa-Gevaert expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Agfa-Gevaert valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| Gross Profit | $407M | XXX | $398M | XXX | XXX | XXX |
| Gross Margin | 31% | XXX | 31% | XXX | XXX | XXX |
| EBITDA | $39.8M | XXX | -$20.2M | XXX | XXX | XXX |
| EBITDA Margin | 3% | XXX | -2% | XXX | XXX | XXX |
| EBIT | -$35.9M | XXX | -$51.7M | XXX | XXX | XXX |
| EBIT Margin | -3% | XXX | -4% | XXX | XXX | XXX |
| Net Profit | -$78.1M | XXX | -$103M | XXX | XXX | XXX |
| Net Margin | -6% | XXX | -8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $41.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Agfa-Gevaert's stock price is EUR 1 (or $1).
Agfa-Gevaert has current market cap of EUR 146M (or $164M), and EV of EUR 268M (or $301M).
See Agfa-Gevaert trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $301M | $164M | XXX | XXX | XXX | XXX | $-0.39 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Agfa-Gevaert has market cap of $164M and EV of $301M.
Agfa-Gevaert's trades at 0.2x EV/Revenue multiple, and -14.9x EV/EBITDA.
Equity research analysts estimate Agfa-Gevaert's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Agfa-Gevaert has a P/E ratio of -2.1x.
See valuation multiples for Agfa-Gevaert and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $164M | XXX | $164M | XXX | XXX | XXX |
| EV (current) | $301M | XXX | $301M | XXX | XXX | XXX |
| EV/Revenue | 0.2x | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | 7.6x | XXX | -14.9x | XXX | XXX | XXX |
| EV/EBIT | -8.4x | XXX | -5.8x | XXX | XXX | XXX |
| EV/Gross Profit | 0.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | -2.1x | XXX | -1.6x | XXX | XXX | XXX |
| EV/FCF | -8.0x | XXX | -5.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAgfa-Gevaert's last 12 month revenue growth is 3%
Agfa-Gevaert's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Agfa-Gevaert's rule of 40 is 7% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Agfa-Gevaert's rule of X is 11% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Agfa-Gevaert and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 3% | XXX | -2% | XXX | XXX | XXX |
| EBITDA Growth | 129% | XXX | 26% | XXX | XXX | XXX |
| Rule of 40 | 7% | XXX | 2% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 11% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Agfa-Gevaert acquired XXX companies to date.
Last acquisition by Agfa-Gevaert was XXXXXXXX, XXXXX XXXXX XXXXXX . Agfa-Gevaert acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Agfa-Gevaert founded? | Agfa-Gevaert was founded in 1964. |
| Where is Agfa-Gevaert headquartered? | Agfa-Gevaert is headquartered in Belgium. |
| How many employees does Agfa-Gevaert have? | As of today, Agfa-Gevaert has 5.0K+ employees. |
| Who is the CEO of Agfa-Gevaert? | Agfa-Gevaert's CEO is Mr. Pascal Juery. |
| Is Agfa-Gevaert publicy listed? | Yes, Agfa-Gevaert is a public company listed on BRU. |
| What is the stock symbol of Agfa-Gevaert? | Agfa-Gevaert trades under AGFB ticker. |
| When did Agfa-Gevaert go public? | Agfa-Gevaert went public in 1999. |
| Who are competitors of Agfa-Gevaert? | Similar companies to Agfa-Gevaert include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Agfa-Gevaert? | Agfa-Gevaert's current market cap is $164M |
| What is the current revenue of Agfa-Gevaert? | Agfa-Gevaert's last 12 months revenue is $1.3B. |
| What is the current revenue growth of Agfa-Gevaert? | Agfa-Gevaert revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Agfa-Gevaert? | Current revenue multiple of Agfa-Gevaert is 0.2x. |
| Is Agfa-Gevaert profitable? | Yes, Agfa-Gevaert is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Agfa-Gevaert? | Agfa-Gevaert's last 12 months EBITDA is $39.8M. |
| What is Agfa-Gevaert's EBITDA margin? | Agfa-Gevaert's last 12 months EBITDA margin is 3%. |
| What is the current EV/EBITDA multiple of Agfa-Gevaert? | Current EBITDA multiple of Agfa-Gevaert is 7.6x. |
| What is the current FCF of Agfa-Gevaert? | Agfa-Gevaert's last 12 months FCF is -$37.4M. |
| What is Agfa-Gevaert's FCF margin? | Agfa-Gevaert's last 12 months FCF margin is -3%. |
| What is the current EV/FCF multiple of Agfa-Gevaert? | Current FCF multiple of Agfa-Gevaert is -8.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
